Tectonic Therapeutic
TECX
70 hedge funds and large institutions have $355M invested in Tectonic Therapeutic in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 8 closing their positions.
213% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 8
63% more capital invested
Capital invested by funds: $217M → $355M (+$137M)
40% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 15
32% more funds holding
Funds holding: 53 → 70 (+17)
3.4% more ownership
Funds ownership: 48.72% → 52.11% (+3.4%)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PBA
Paradigm Biocapital Advisors
New York
|
+$20.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.5M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$8.15M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$5.42M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AVLSA
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
-$12.7M |
| 2 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$6.42M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$5.28M |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$4.17M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$3.75M |
TECX Hedge Fund Activity: Q4 2024 in Review
70 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q4 2024, worth a combined $355M — up 63% from $217M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new TECX positions and 8 closed out — a net gain of 17 holders — while 21 added to existing stakes and 15 trimmed.
The largest buyer was Paradigm Biocapital Advisors, opening a new position worth an estimated $20.5M. The largest seller was Atlas Venture Life Science Advisors, cutting an estimated $12.7M.
- 70 institutional investors held Tectonic Therapeutic (TECX) as of Q4 2024, up from 53 in Q3 2024.
- Funds reported $355M of Tectonic Therapeutic stock for Q4 2024, up 63% quarter-over-quarter.
- 25 funds opened new Tectonic Therapeutic positions in Q4 2024 and 8 closed out, a net change of +17 holders.
- The largest Tectonic Therapeutic buyer in Q4 2024 was Paradigm Biocapital Advisors, an estimated $20.5M added.
- The largest Tectonic Therapeutic seller in Q4 2024 was Atlas Venture Life Science Advisors, an estimated $12.7M sold.
Based on aggregated 13F filings for Q4 2024.